×
Home Schedule Organizers Additional Information Sponsors CORPORATE PARTNERS ZONE Contact Back to portal fr

Schedule

22nd ANNUAL MEETING OF FONDATION D.E.V.E.N.I.R.

Organized in collaboration with the SQN

Day 1 program Day 2 program Corporate zone
Skills development in the CanMEDS roles targeted by this activity:
Accreditation

This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, and a Recognized Professional Development Activity (Category A) as defined by the Collège des médecins du Québec. This activity was approved by the direction de Développement professionnel continu (DDPC) of the Fédération des médecins spécialistes du Québec.

You may claim a maximum of 8.5 Accredited Group Learning Activity (Section 1) / Recognized Professional Development Activity (Category A) hours. Participants must claim a number of hours consistent with their attendance.

GENERAL OBJECTIVES
  1. To promote, through multidisciplinarity, a comprehensive healthcare approach for clients with chronic kidney disease and for related co-morbid clinical conditions.
  2. To generate optimal use of the skills of the members of the multidisciplinary teams (physicians, pharmacists, nurses, dietitians), in the healthcare process for this client group.

*** NOTE: For the 22nd ANNUAL CONFERENCE OF FONDATION D.E.V.E.N.I.R., participants can register and join either the half-day session of this continuing medical education on October 4th or the half-day session on Saturday, October 5th, or opt for both half-day sessions. ***

The specific objectives for each conference are indicated at the end of the program (see below).

SCIENTIFIC PROGRAM – DAY 1

Note: A simultaneous translation service from English to French and from French to English will be available. You must bring your headphones and your electronic devices for accessing the translation service.

Friday October 4th, 2024

11:30 - 13:00
ARRIVAL OF PARTICIPANTS (Registration)
13:00 - 13:15
OPENING REMARKS

Dr. Daniel Garceau

OVERVIEW OF SCIENTIFIC PROGRAM

Dr. Louis-Denis Poulin

13:15 - 14:15
“ARTIFICIAL INTELLIGENCE IN NEPHROLOGY: FOR NOW, OR FOR LATER?”

Dr. Wisit Cheungpasitporn

“ARTIFICIAL INTELLIGENCE IN NEPHROLOGY: FOR NOW, OR FOR LATER?”

14:15 - 15:15
“AUTOIMMUNE DISEASES, VASCULITIS AND PREGNANCY; HOW TO TRANSFORM A DREAM TO REALITY!”

Prof. Angela Tincani

“AUTOIMMUNE DISEASES, VASCULITIS AND PREGNANCY; HOW TO TRANSFORM A DREAM TO REALITY!”

15:15 - 15:50 - HEALTH BREAK Corporate zone
15:50 - 17:55
“HIGHLIGHTS IN 2024 TO SHARE”

(Lectures in French)

15:50-16:15: The Nurse’s / SNP’s Vision - Ms. Isabelle Vaillant

16:15-16:40: The Pharmacist’s Vision - Ms. Jodianne Couture

16:40-17:05: The Nephrologist’s Vision - Dr. Philippe Lachance

17:05-17:30: The Nutritionist’s Vision - Ms. Roxanne Papineau

17:30-17:55: Question Period

“HIGHLIGHTS IN 2024 TO SHARE”

18:30 - 19:30
COCKTAIL
19:30 - 22:00
DINNER
SCIENTIFIC PROGRAM – DAY 2

Note: Simultaneous translation from English to French and from French to English will be available. You must bring your headphones and electronic devices to benefit from the translation service.

Saturday October 5th, 2024

7:00 - 8:00
BUFFET BREAKFAST
8:00 - 8:10
OPENING REMARKS

Dr. Daniel Garceau

OVERVIEW OF SCIENTIFIC PROGRAM

Dr. Louis-Denis Poulin

8:10 - 9:10
“WATER AND SALT INTAKE WITH CKD; IS IT TOO MUCH OR NOT ENOUGH?”

Dr. Biff F. Palmer

“WATER AND SALT INTAKE WITH CKD; IS IT TOO MUCH OR NOT ENOUGH?”

9:10 - 9:40
“A KIDNEY GRAFT RECIPIENT; THE BEGINNING AND THE END OF THE STORY” PART 1
“PREEMPTIVE KIDNEY GRAFT: A USER GUIDE”

Dr. Michelle A. Josephson

“A KIDNEY GRAFT RECIPIENT; THE BEGINNING AND THE END OF THE STORY” PART 1
“PREEMPTIVE KIDNEY GRAFT: A USER GUIDE”

9:40 - 10:10
“A KIDNEY GRAFT RECIPIENT; THE BEGINNING AND THE END OF THE STORY” PART 2
“THE FAILING KIDNEY GRAFT; ANOTHER USER GUIDE FOR HEALTHCARE PROFESSIONALS INVOLVED IN CKD CARE”

Dr. Michelle A. Josephson

“A KIDNEY GRAFT RECIPIENT; THE BEGINNING AND THE END OF THE STORY” PART 2
“THE FAILING KIDNEY GRAFT; ANOTHER USER GUIDE FOR HEALTHCARE PROFESSIONALS INVOLVED IN CKD CARE”

10:10 - 10:25
JOINT Q&A AND DISCUSSION SESSION
10:25 - 11:00 - HEALTH BREAK Corporate zone
11:00 - 11:30
“SHARED DECISION MAKING IN CKD; A PATIENT’S AND A CAREGIVER’S PERSPECTIVE” PART 1
“SHARED DECISION MAKING: WHAT IS THE LITERATURE AND RESEARCH TELLING US IN 2024?”

(Lecture in French)

Dr. Patrick Archambault

“SHARED DECISION MAKING IN CKD; A PATIENT’S AND A CAREGIVER’S PERSPECTIVE” PART 1
“SHARED DECISION MAKING: WHAT IS THE LITERATURE AND RESEARCH TELLING US IN 2024?” (Lecture in French)

11:30 - 11:55
“SHARED DECISION MAKING IN CKD; A PATIENT’S AND A CAREGIVER’S PERSPECTIVE” PART 2
“SHARED DECISION MAKING IN CKD; A PATIENT’S PERSPECTIVE”

(Lecture in French)

Mr. Réjean Lemoine

“SHARED DECISION MAKING IN CKD; A PATIENT’S AND A CAREGIVER’S PERSPECTIVE” PART 2
“SHARED DECISION MAKING IN CKD; A PATIENT’S PERSPECTIVE” (Lecture in French)

11:55 - 12:25
JOINT Q&A AND DISCUSSION SESSION
12:25 - 12:35
CLOSING WORDS

Dr. Daniel Garceau

Dr Louis-Denis Poulin

12:35 - 13:45
BUFFET LUNCH

Note: This program receives unrestricted educational grants from pharmaceutical companies Amgen Canada and Otsuka Canada without any regards to the choice of speakers, topics, choice of members of the scientific committee. We also offer our thanks to Amgen Canada as exhibitor.